chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report received from a health care professional via other manufacturer (Pfizer) concerned a 41 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was not pregnant at the time of this report. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose not reported, 01 total administered on an unspecified date for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s. The patient additionally received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose not reported, 01 total administered on an unspecified date for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (dose number in series 2).  The patient received with elasomeran (Moderna) (dose number in series 3) (form of admin and route of admin were not reported, batch number: unknown expiry: unknown) dose was not reported, administered on an unspecified date for covid-19 prophylaxis.  On an unspecified date in JUN-2022 patient had COVID-19. The patient took unspecified drug from 22-JUN-2022 till 27-JUN-2022 for Coronavirus Disease (COVID 19). On 01-JUL-2022 the patient experienced rebound 4 days after completing treatment with an unspecified drug. Worse symptoms than originally reported (dose number in series 3). Treatment medications (dates unspecified) included: prednisone, Short Acting Beta Agonists (SABAs). The action taken with covid-19 vaccine ad26.cov2.s, and elasomeran was not applicable and with unspecified drug was drug discontinued. The patient had not recovered from rebound 4 days after completing treatment. worse symptoms than originally reported. This report was non-serious.
Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Additional Details: Patient stated her lips felt tingly and started to swell.  Patient took her own children's benadryl 12.5mg chewables x 3 doses and sat for 30 minutes.  Symptoms resolved in minutes of taking benadryl.  Patient left with Mom & Dad driving.
Headache, swollen at site, inflammation at site, heavy redness on entire upper arm.
Flu injection given on 10/10/2011. Mother called to report swollen and red area at injection site that same evening. It was still red-size of a baseball on 10/11/11 with less swelling. No fever. No difficulty breathing.
Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: patient states "arm feels weird" kind of numb"
I woke up at about 4:30 am shivering.  Got an additional blanket and tried to warm myself.  snuggled into husbands back to get very nauseated and vomited several times.  Slept most of the day with little appetite.  Had difficulty maintaining body temp but never ran a temperature.  Lots of body aches.
I experienced a virtual repeat of all of the Covid 19 symptoms in mid-February that culminated in pneumonia.  This time, I did not take any additional medications or treatments.  I emailed this note to my physician on March 17: "I?m very concerned about my health, especially since my cough and congestion issues returned with a vengeance on Sunday night/Monday morning (March 14 & 15).  They appear to be continuing unabated, and I?m not aware of any treatment plan to address those problems. History ? My current health issues first began on Sunday evening, February I4 when I started to experience essentially all of the symptoms for the COVID virus.   ? I drove in and was tested for Covid on Tuesday, February 16.  It came back negative, but I continued to experience much coughing and nasal congestion.   ? I called Dr. on February 19 and he prescribed Amoxicillin and Clavulanate tablets on February 19, which I began taking that day.   ? The symptoms did not really dissipate, so I came in to see Dr. on February 25.   I again tested negative for Covid but an x-ray showed I had pneumonia.  He had me discontinue taking the Amoxicillin and put me on two other antibiotics, Azithromycin 250 mg Pak Tab TE and Cefpodoxime (200 mg).  I immediately started taking them.  They seemed to be effective.  ? I felt very good at the beginning of the week of March 8, so I worked out three times, bowled on Thursday, saw you on Friday afternoon, March 12, and got my Moderna vaccine shot the following  morning.  You scheduled me for a follow-up chest x-ray for me for Friday, March 19.   ? Unfortunately, my upper respiratory problems - lots of coughing, heavy head congestion, and sporatic bouts of sneezing ? returned with a vengeance on Monday, March 15.  Sleeping is now an issue. ? Today, March 16, I spoke with your nurse and moved my chest x-ray up to Thursday.   Issues I?m hoping you will be able to speak with me on Thursday to address my questions & concerns.  Here they are: ? Are the problems I'm having now a result of my vaccination shot? How does one determine that? If that's the case, can anything be done to decrease the coughing & congestion?  How long will it take to recover? ? If I?m not reacting to the Moderna vaccine, what is my problem and what can be done about it? Also, what?s the prognosis? ? Does Clinic have an established treatment plan for those diagnosed with COVID? If so, what is it? ? Given what happened after my initial Moderna shot, I'm thinking about skipping the 2nd one since the literature says it usually causes more patient problems than the 1st one.  What are his thoughts on this?"
With fever and chills for 2 days as well as fatigue for several days after. Pt specifically requests we report this reaction.
Initial report received on 18/Aug/2006 from a health care professional.  A 30 year-old female patient with no current illnesses had received a left deltoid dose of Adacel, lot number C2559AA, on 15/Aug/2006.  The route of administration was not reported.  The next day, the patient experienced a left deltoid, 3 x 4 cm area of redness, warmth, swelling and itchiness.  Per the reporter, the patient had no fevers and was seen in the physician's office two days later with persisting symptoms.  Treatment received was not reported.  The recovery status of the patient was reported as not recovered.  The reporter for this case is the same as for case number reported.
Pentacel given instead of Kinrix    Patient received an extra dose of Hib     No known adverse effects
TIRED; BODY ACHES; SWOLLEN GLANDS; This spontaneous report received from a patient concerned a 63 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included sulfa allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 08-MAR-2021 08:20 for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced swollen glands. On 10-MAR-2021, the subject experienced tired. On 10-MAR-2021, the subject experienced body aches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swollen glands, tired, and body aches. This report was non-serious.
I had given the pt the 5-11 year covid shot and not the 12+ one. I thought the pt was 11 years old. I got confused with his age. So I gave him with 5 -11 yr one and realized when I was charting it before the end of the day. . Pt did not show signs of symptoms when I was thier in the room with
Anxious, heart racing, 4 cc erythematous area around site of injection (L) deltoid.
Information has been received from a physician concerning an 82 year old female who in approximately March 2005, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot # 647655/1041P). The patient was also being treated with unspecified antibiotics for a urinary tract infection. Shortly after the vaccination, the patient developed shoulder pain above the injection site. The pain had severely restricted the range of motion of the left shoulder. The physician noted that this was the first time that she had seen someone's shoulder totally locked up like that. No swelling, redness, or warmth seemed to be present at or near the infection site. The injection site was not irritated at all, and the physician believes that this may be more a Munchausen's syndrome. The patient was treated with ibuprofen, and acetaminophen (+) codeine phosphate. X-ray results were pending. It was recommended that the patient seen an orthopedist. It was noted that the patient probably has arthritis in the joint. It was also reported that the patient had a previous vaccination with pneumococcal 23v polysaccharide vaccine and did not have a reaction at all. The patient's daughter (who is a medical assistant) had stated that her mother had at least two or three past vaccinations with pneumococcal 23v polysaccharide vaccine. The patient had stated that she had received only one other dose. At the time of report, the patient's symptoms have remained. No product quality complaint was involved. The physician noted that shoulder pain and restricted range of motion of the left shoulder were considered other important medical events (OMIC). Additional information has been requested.
Body aches, chills, headache, joint pain, fatigue. Red spot on left upper arm below the injection site.
PATIENT WAS 10 YEARS OLD AND RECEIVED THE 0.3 ML / 30 MCG DOSE. MONITORED PATIENT FOR ADVERSE REACTIONS. NO ADVERSE REACTIONS OCCURED. PATIENT STATED BEING FINE AND MOTHER WAS PRESENT.
Headache, Myalgia & CoughWheeze developed sx within 90 sec of vaccine intermittent for ten days. received vaccination at hospital.
2-3 hours after receiving IM broke out in rash on face & neck x 3 days used OTC BENADRYL & resolved without Rx. Reported to office 2wks later on 8/12/10.
This spontaneous report as received from a nurse refers to a 16 year old patient of an unknown gender. On 14-JAN-2015, the patient was vaccinated with improperly stored GARDASIL (lot # K007264 and expiry date: 02-MAR-2017). No adverse events were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information has been requested.
Fever to 101.8 degrees and chills.   Lasted approximately to 6 AM on 2/3/2021 and kept coming down.   On morning of 2/4/2021,Allowed to go back to work.   Employee health would not allow to work until fever free for 24 hours
Pt had dyspnea and throat swelling after leaving the vaccination site on the way home. She called 911 and was transported to the hospital.
Loss of taste and partial smell; Loss of taste and partial smell; Hard to talk or eat or drink; Hard to talk or eat or drink; Hard to talk or eat or drink; Bells Palsy; Blurry vision; Fever; Felt achy; This is a spontaneous report from a contactable consumer (patient).  This 69-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9261), via an unknown route, on 29Jan2021 (at 10:00 AM) at a single dose in the left arm for COVID-19 immunisation. Relevant medical history includes diabetes, arteriolosclerosis, blocked carotid artery, gastrooesophageal reflux disease (GERD) and chronic prostatitis. Past drug history included allergy to penicillin and cefixime (FLEXERIL). Relevant concomitant medications included doxazosin mesylate (CARDURA), lisinopril, metformin, omeprazole, repaglinide (PRANDIN) and other unspecified medications. He had fever and felt achy for a couple of day. On 03Feb2021 (at 08:00), the patient had total paralyzed on right side of his face, right eye will not close, mouth paralyzed on right side. Hard to talk or eat or drink. Blurry vision in right eye due to not closing. On 04Feb2021, the patient has loss of taste and partial smell. The patient performed physician office visit. Then, he went to the emergency room (ER) and Bells Palsy was confirmed on 06Feb2021. He stated that his blood work is currently fine. He was given prednisone and acyclovir for Bells Palsy and for hard to talk or eat or drink. The patient was not treated for the remaining events. Pre and post vaccination COVID test were not performed. All events were considered serious for disability except of fever and felt achy. The outcome of the events fever and felt achy was unknown while the outcome of the remaining events was not recovered.
I had my vaccination on 09/16/2022. On 10/14/2022 I started to get hoarse and coughing. I tested COVID-19 Positive on 10/17/2022. I went to the clinic and connected with my pulmonologist. Isolation for 7 days and take medication for 5 days.
I don't know to look back, it was a mistake. I had a few medical issues. I always get a septic infection when getting sick. I have been careful, but contracted COVID-19 from a family member. I went to the urgent care. I had aches and pains all over, feverish and weak. I was having flu like symptoms. I was prescribed PAXLOVID. I had this awful taste in my mouth all the time. I am doing better now but I am really stuffed up with a small cough.
A report has been received from a Health Professional concerning a 13 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 04-Dec-2013. It was reported that the patient received expired FLUMIST on 04-Dec-2013. Not reported any symptoms. The outcome of the event of administration of expired dose is unknown. The report was considered to be non-serious.
Injection given on 30th at about 13:00 - "woke up on 31st with pain, redness and swelling the diameter of a baseball". Took Motrin for discomfort, no change until 2nd when swelling was at elbow 20 x 12 cm. Subsided over a 5 day period. Completely gone today.
No adverse event; gave them the 6 months to 5 years of age vaccine and the patient was an adult; gave them the 6 months to 5 years of age vaccine and the patient was an adult; This spontaneous case was reported by an other health care professional and describes the occurrence of INCORRECT DOSE ADMINISTERED (gave them the 6 months to 5 years of age vaccine and the patient was an adult), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave them the 6 months to 5 years of age vaccine and the patient was an adult) and NO ADVERSE EVENT (No adverse event) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. AS1412B, 047C21A and 047C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Aug-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Aug-2022, the patient experienced INCORRECT DOSE ADMINISTERED (gave them the 6 months to 5 years of age vaccine and the patient was an adult) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave them the 6 months to 5 years of age vaccine and the patient was an adult). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INCORRECT DOSE ADMINISTERED (gave them the 6 months to 5 years of age vaccine and the patient was an adult), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave them the 6 months to 5 years of age vaccine and the patient was an adult) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INCORRECT DOSE ADMINISTERED (gave them the 6 months to 5 years of age vaccine and the patient was an adult) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (gave them the 6 months to 5 years of age vaccine and the patient was an adult).    Patient height was reported as 63 inches. Patient had no Allergies. No Concomitant medications were provided. Patient did not received other vaccines given within 1 month prior to Moderna COVID-19 vaccine. AE did not cause patient to seek medical care. It was unknown whether patient experienced a similar event in the past. It was unknown whether patient symptoms improved or worsened. Patient never had COVID positive test or diagnosis. No treatment medications were provided.
On July 30, 2022 I started having a headache, nausea and diarrhea. On 7-31, I took a home COVID-19 test with negative results. On 8-1, I took another home COVID-19 test with positive result. I called the doctors office and had a telehealth visit. They ordered a prescription for PAXLOVID. I started the medication on that same day. I am reporting a breakthrough case of COVID-19.
Sore arm at injection site started a few hours after the vaccine and lasted about 48 hours. About 12 hours after vaccine, fever, chills, headache started, lasting over 24 hours. Additionally diarrhoea began on day of vaccine and lasted 3 days. Indigestion and stomach pains also started the day after the vaccine and are still persisting, now 5 days later.
Information has been received from a physician, via a company representative, concerning a 14 year old female patient, who was vaccinated IM (date not specified), with the second dose of GARDASIL (Lot # not provided). The following day (24 hours post vaccination), the patient developed swollen glands. After an unknown duration of time, the patient recovered. The patient sought unspecified medical attention. Additional information has been requested.
Crying-screaming for two hours, rigid-stiff, fever 100. Gave Motrin.
64 Y female vaccinated for COVID (Pfizer 2 shots series in March) with hx significant for hyperlipidemia,  hypertension, psoriasis, diabetes mellitus (last HgA1c:6.7), obesity, OSA using nocturnal CPAP who presented 12/09 with worsening SOB, COVID +. Sx onset 12/1 and COVID + here 12/3, with acute worsening 12/07-12/09. Patient received remdesivir (12/9-12/13), toci x2 (12/11, 12/12), started on steroids. Patient required ICU from 12/11-12/22 and required iNO. Patient s/p high dose solu medrol, now on prednisone taper. Patient subsequently had improving oxygenation, transferred onto floors with continued improvement, stable on NC O2.   # COVID PNA - vaccinated pfizer x2 in March 2021. Sxs onset 12/1/2021. COVID + test 12/3. iNO off 12/21. S/p remdesivir x5d (12/9/21-12/13), tocilizumab x2 (12/11-12/12), solumedrol x5 day. Deisolated on 12/23. - s/p solumedrol taper, currently on taper with prednisone 60mg BID starting 12/22 for 3d, then prednisone 60mg daily x 3d, 40mg daily x 3d, 30mg daily x 3d, 20mg daily x 3d, then 10mg daily x 3d, then stop- last dose 1/8/22 - pepcid for ppx while on steroids - Sildenafil 10mg x2 started 12/21, 10mg x1 on 12/22 - Cont to wean O2 as tolerated, oxygen clinic on dc - combivent QID - lovenox 40 BID - for ppx, currently not planned to continue on dc, as patient with good improvement, good mobility - f/u oxygen clinic, econsult placed   # DM2 - last A1c 6.7 10/202, not on PTA insulin. PTA had metformin.  - Lispro ISS high dose - will dc on 20 lantus daily - SSI on dc - adjust as patient on steroid taper, f/u diabetes CCM - insulin teaching done   # Allergies - PTA claritin - PTA flonase   # OSA - CPAP as tolerated    # HTN, HLD - lipitor 20 daily - losartan 50 daily  Reason for Hospital Admission (Admitting Diagnosis):  COVID
losing his balance; Seem to be losing balance was reported as worsened; booster; feet are a little crooked; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 72 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 (Lot number: FF2590, Expiration Date: 31Dec2021) at the age of 72 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose, Date of administration-05Mar2021, lot: ENG199 or EN6199, caller clarifies he does think the lot is EN6199., Route of administration: Left Upper arm), administration date: 05Mar2021, when the patient was 72 years old, for COVID-19 immunization; Bnt162b2 (Second dose: 02APR2021, lot number: EP6955, NDC: Unknown, Expiration: Unknown, Route of administration: Left or right upper arm), administration date: 02Apr2021, when the patient was 72 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 12Nov2021, outcome "unknown", described as "booster"; BALANCE DISORDER (non-serious) with onset 13Nov2021, outcome "not recovered", described as "losing his balance"; CONDITION AGGRAVATED (non-serious) with onset 13Nov2021, outcome "unknown", described as "Seem to be losing balance was reported as worsened"; LIMB DISCOMFORT (non-serious) with onset Nov2021, outcome "unknown", described as "feet are a little crooked".  Additional information: The patient had no side effects after receiving the first and second dose Pfizer Covid 19 Vaccine. He got his first and second dose of the covid vaccine without experiencing any side effects. He said he got his booster dose last 12Nov2021 and a day after, he started losing his balance and "getting a little bit worse" so far.   Follow-up attempts are completed. No further information is expected.